Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Adagene Inc. American Depositary Shares (ADAG)

https://www.adagene.com

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/09/2021

Market Cap

112,244,146

Shares Outstanding

54,720,000

Weighted SO

43,834,671

Total Employees

N/A

Upcoming Earnings

08/26/2021

Similar Tickers

AVTE --.--%

ACRV --.--%

RZLT --.--%

ANTX --.--%

ANEB --.--%

ANAB --.--%

MLYS --.--%

ELYM --.--%

JANX --.--%

Beta

0.6500

Last Div

0.0000

Range

1.1-4.38

Chg

0.0254

Avg Vol

16398

Mkt Cap

112244146

Exch

NASDAQ

Country

CN

Phone

86 512 8777 3632

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

90.4314

EV Multiple

-1.0360

P/FV

1.9791

Div Yield %

0.0000

P/E

-2.3286

PEG

-0.0500

Payout

0.0000

Current Ratio

2.5003

Quick Ratio

2.5003

Cash Ratio

2.4210

DSO

9.2390

DIO

0.0009

Op Cycle

9.2399

DPO

2891.6424

CCC

-2882.4025

Gross Margin

0.6572

Op Margin

-45.0839

Pretax Margin

-39.5081

Net Margin

-38.7476

Eff Tax Rate

0.0066

ROA

-0.4772

ROE

-0.7565

ROCE

-0.9134

NI/EBT

0.9808

EBT/EBIT

0.8763

EBIT/Rev

-45.0839

Debt Ratio

0.2052

D/E

0.3654

LT Debt/Cap

0.0746

Total Debt/Cap

0.2676

Int Coverage

-57.4427

CF/Debt

-0.6468

Equity Multi

1.7809

Rec Turnover

39.5063

Pay Turnover

0.1262

Inv Turnover

425462.0000

FA Turnover

0.7331

Asset Turnover

0.0123

OCF/Share

-0.3028

FCF/Share

-0.3031

Cash/Share

2.1660

OCF/Sales

-10.7748

FCF/OCF

1.0009

CF Coverage

-0.6468

ST Coverage

-0.8298

CapEx Coverage

-1065.8047

Div&CapEx Cov

-1065.8047

P/BV

1.9791

P/B

1.9791

P/S

90.4314

P/E

-2.3286

P/FCF

-8.3850

P/OCF

-8.3739

P/CF

-8.3739

PEG

-0.0500

P/S

90.4314

EV Multiple

-1.0360

P/FV

1.9791

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 16, 17:01 Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

Revenue Product Segmentation